Canonical Cannabinoid Receptors.
Level 5 - mechanism / opinion, no new human data
Narrative review of receptor biology and molecular pharmacology without new empirical data
PubMed 40050540 · doi:10.1007/7854_2024_556
What was done
This review summarizes the basic pharmacology, distribution, intracellular signalling cascades, and regulation of the canonical cannabinoid receptors CB1 and CB2, focusing on their mechanisms in the central nervous system and peripheral immune regulation.
What was found
The abstract reports no numerical findings or statistical measures. It describes qualitative mechanistic functions: CB1 receptors are primarily enriched in the central nervous system where they regulate neurotransmitter release, synaptic plasticity, ion channels, second messengers, and protein kinases, whereas CB2 receptors are mainly expressed in immune cells and peripheral tissues involved in anti-inflammatory processes.
Why it matters
It outlines fundamental molecular and physiological mechanisms governing endocannabinoid signalling across neural and immune pathways.
Limits
As a narrative review, it lacks a systematic literature search strategy, meta-analytic pooling, and direct experimental data. The abstract provides purely descriptive pharmacology without quantitative effect sizes or clinical data.
Cited by
- supports Cannabinoids suppress the immune system and operate primarily through two receptor types: cannabinoid receptor type 1 predominantly on neurons, and cannabinoid receptor type 2 predominantly on immune cells.